… cytokine release in response to viral infection, a condition known as cytokine release
syndrome (CRS) or cytokine storm… timed anti-inflammatory therapeutic strategies could improve …

… However, a meta-analysis of clinical trials indicated no clinical benefits of HCQ treatment
in … Early control of the cytokine storm through therapies, such as immunomodulators and …

… of therapeutic plasma exchange (TPE) to treat cytokine storm … cytokines from the blood
and can improve cytokine storm 7 . … have demonstrated the clinical benefits of TPE in severe …

… T-cell therapy could help to distinguish CRS from a cytokine storm (2)… laboratory criteria to
identify the cytokine storm. In this review… corticosteroids might have some benefit for critically ill …

… underlying cytokine storm induction … cytokine storms are described from both host and
pathogen perspectives. In summary, current studies indicate that cytokine storm-targeted therapies …

… Reports of hemophagocytosis and clinical benefits from cytokine-targeted therapies in
severe COVID-19 patients further confirmed the existence and pathogenesis of COVID-CS. …

… therapies and monoclonal antibodies cause cytokine release syndrome. Efforts are being
carried out to maximize the chance for therapeutic benefit from … of sustained cytokine release. …

… cytokine storm is a hyperinflammatory state secondary to the excessive production of cytokines
… The term cytokine storm was first used in 1993 to describe the graft-versus-host disease …

… (cytokine storm) and tissue damage. Some drugs have been studied as therapeutic targets
(block to viral entry or to cytokine storm) … A study with control group showed no benefit from …

… of the inflammatory response and cytokine storm in increased … It is important to select
patients who may benefit from these … along with suggested antiviral therapies can be effective in …